Skip to main navigation Skip to search Skip to main content

Evolution of Major Clinical Trials in ROP

  • Bascom Palmer Eye Institute

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Retinopathy of prematurity (ROP) is a vasoproliferative disorder occurring in premature infants’ retinas. With the advances in neonatal care in recent years, ophthalmologists are increasingly encountering premature babies, who have higher risks of developing ROP. The occurrence and severity of ROP depend on several factors, which have been reported by various clinical trials. This chapter demonstrates the evolution of several aspects of major clinical trials in ROP, including its treatment, the role of oxygen in ROP development, and the roles of light and nutrients in ROP.

Original languageEnglish
Title of host publicationA Quick Guide to Pediatric Retina
PublisherSpringer Nature
Pages21-27
Number of pages7
ISBN (Electronic)9789811565526
ISBN (Print)9789811565519
DOIs
Publication statusPublished - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clinical trials
  • Light
  • Retinopathy of prematurity
  • Treatment Oxygen

Fingerprint

Dive into the research topics of 'Evolution of Major Clinical Trials in ROP'. Together they form a unique fingerprint.

Cite this